Hongcheon Bio Companies Harness AI for Next-Generation Atopic Dermatitis Treatment Development
L&P Solution and K-Medichem
Selected for Ministry of SMEs and Startups Technology Development Project
Connecting AI-Based Design, Synthesis, and Pharmacological Evaluation
Aiming to Secure Preclinical Candidate Substances
New drug development companies in the Gangwon region are joining forces with artificial intelligence (AI)-based pharmaceutical research firms to develop next-generation treatments for atopic dermatitis.
L&P Solution, a tenant company of the Hongcheon National Antibody Cluster, together with K-Medichem located in Chuncheon, has been selected for the AI-based candidate substance discovery project under the "2026 Pharmaceutical Bio Venture Collaboration-Based Technology Development Project" hosted by the Ministry of SMEs and Startups. Provided by Hongcheon County
View original imageOn September 7, Hongcheon County announced that L&P Solution, a tenant company of the Hongcheon National Antibody Cluster, together with Chuncheon-based K-Medichem, has been selected for the AI-based candidate substance discovery project under the "2026 Pharmaceutical Bio Venture Collaboration-Based Technology Development Project" sponsored by the Ministry of SMEs and Startups.
A total of 1 billion won will be invested in the project over the next two years. K-Medichem will take the lead as the main research institution, while L&P Solution will participate as a joint research institution.
The two companies plan to combine AI-based drug design technology with medicinal chemistry, synthesis, and pharmacological evaluation capabilities to discover next-generation candidates for atopic dermatitis therapies. Their goal is to secure candidate substances with new mechanisms of action and improved selectivity to overcome the limitations of existing treatments, and to advance these candidates into the preclinical development stage.
Atopic dermatitis is a chronic inflammatory skin disease that requires long-term treatment, making not only drug efficacy but also safety and selectivity crucial. The two companies' strategy centers on utilizing AI to precisely design candidate substances, and optimizing their structure through medicinal chemistry technology to enhance both efficacy and drug-like properties.
They will also build a data feedback system that continuously compares and analyzes AI predictions with actual experimental data. Experimental outcomes will in turn be reflected back into candidate substance design, with the aim of achieving both "predictable drug development" and "AI-powered new drug development validated by experiments."
This is not the first collaboration between the two companies. Since signing a strategic partnership agreement in November 2023, they have continued joint research through participation in the National New Drug Development Project in 2025 and the Regional Leading Pioneer Enterprise Development Project in 2026, among others.
The partnership is especially significant because it enables Gangwon-region companies to tackle state-funded, advanced new drug development projects by integrating their technologies, at a time when new drug development infrastructure is concentrated in the Seoul metropolitan area. The two companies aim to develop this into a Gangwon-style new drug development cooperation model that will enhance the competitiveness of the regional AI-bio convergence industry.
K-Medichem specializes in the development of new drugs and bioactive materials based on natural products, as well as the design and synthesis of candidate substances utilizing medicinal chemistry. L&P Solution is an in silico drug discovery company that incorporates AI and deep learning technologies into computer simulation-based molecular modeling.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
An official from Hongcheon County stated, "This selection is the result of L&P Solution's innovative capabilities, the infrastructure of the Hongcheon National Antibody Cluster, and our bioventure development policies. We will nurture Hongcheon as a key hub for Korea's bioindustry by expanding research infrastructure, improving living conditions, and providing administrative support."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.